These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 37110517

  • 21. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
    Chen F, Yang J, Fang M, Wu Y, Su D, Sheng Y.
    J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
    [Abstract] [Full Text] [Related]

  • 22. A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer.
    Jiao Y, Li S, Wang X, Yi M, Wei H, Rong S, Zheng K, Zhang L.
    Front Immunol; 2022 Apr; 13():929846. PubMed ID: 35990656
    [Abstract] [Full Text] [Related]

  • 23. Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.
    Li C, Zheng L, Xu G, Yuan Q, Di Z, Yang Y, Dong X, Hou J, Wu G.
    Front Endocrinol (Lausanne); 2023 Apr; 14():1154741. PubMed ID: 37538794
    [Abstract] [Full Text] [Related]

  • 24. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M, Wu D, Zhou K, Li H, Gong X, Wei Q, Du M, Lei P, Zha J, Zhu H, Gu X, Huang D.
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [Abstract] [Full Text] [Related]

  • 25. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer.
    Wang Y, Xu Y, Zhang Y.
    Medicine (Baltimore); 2022 Aug 05; 101(31):e29573. PubMed ID: 35945765
    [Abstract] [Full Text] [Related]

  • 26. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y, Wei X, Han Q, Le J, Ma Y, Lin X, Xu Y, Liu N, Wang X, Kong X, Gu J, Tong Y, Wu H.
    BMC Cancer; 2021 Oct 30; 21(1):1165. PubMed ID: 34717566
    [Abstract] [Full Text] [Related]

  • 27. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
    Pan Y, Zhang Q, Zhang H, Kong F.
    Funct Integr Genomics; 2023 Jan 14; 23(1):38. PubMed ID: 36640225
    [Abstract] [Full Text] [Related]

  • 28. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA.
    Xiong Y, Kong X, Fang K, Sun G, Tu S, Wei Y, Ouyang Y, Wan R, Xiao W.
    Mol Biol Rep; 2023 Sep 14; 50(9):7405-7419. PubMed ID: 37452900
    [Abstract] [Full Text] [Related]

  • 29. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma.
    Shi Y, Zhang Y, Zuo N, Wang L, Sun X, Liang L, Ju M, Di X.
    Medicine (Baltimore); 2023 Jun 09; 102(23):e33994. PubMed ID: 37335630
    [Abstract] [Full Text] [Related]

  • 30. Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer.
    Yang M, Sun Y, Ji H, Zhang Q.
    Ann Transl Med; 2022 Dec 09; 10(24):1399. PubMed ID: 36660659
    [Abstract] [Full Text] [Related]

  • 31. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    Zhang X, Zhang M, Zhang X, Zhu X, Wang J.
    BMC Med Inform Decis Mak; 2020 Jul 09; 20(Suppl 3):136. PubMed ID: 32646427
    [Abstract] [Full Text] [Related]

  • 32. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L, Fang H, Guo F, Yin M, Long H, Weng G.
    J Clin Lab Anal; 2022 Aug 09; 36(8):e24582. PubMed ID: 35808868
    [Abstract] [Full Text] [Related]

  • 33. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs.
    Gao Y, Ren J, Chen K, Guan G.
    J Gastrointest Oncol; 2024 Feb 29; 15(1):203-219. PubMed ID: 38482248
    [Abstract] [Full Text] [Related]

  • 34. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
    Zeng J, Li M, Dai K, Zuo B, Guo J, Zang L.
    Pathol Oncol Res; 2022 Feb 29; 28():1610643. PubMed ID: 36419649
    [Abstract] [Full Text] [Related]

  • 35. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
    Wang N, Hu Y, Wang S, Xu Q, Jiao X, Wang Y, Yan L, Cao H, Shao F.
    Sci Rep; 2024 Jan 05; 14(1):624. PubMed ID: 38182642
    [Abstract] [Full Text] [Related]

  • 36. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J, Huang Z, Lin H, Cheng W, Lai J, Li J.
    BMC Cancer; 2022 Nov 04; 22(1):1132. PubMed ID: 36333719
    [Abstract] [Full Text] [Related]

  • 37. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma.
    Huang E, Ma T, Zhou J, Ma N, Yang W, Liu C, Hou Z, Chen S, de Castria TB, Zeng B, Zong Z, Zhou T.
    Ann Transl Med; 2022 Jul 04; 10(14):766. PubMed ID: 35965795
    [Abstract] [Full Text] [Related]

  • 38. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma.
    Zhu J, Zhao W, Yang J, Liu C, Wang Y, Zhao H.
    Anticancer Drugs; 2024 Jun 01; 35(5):466-480. PubMed ID: 38507233
    [Abstract] [Full Text] [Related]

  • 39. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
    Xiang X, Guo Y, Chen Z, Zhang F, Huang J, Qin Y.
    Medicine (Baltimore); 2022 Dec 23; 101(51):e32558. PubMed ID: 36595859
    [Abstract] [Full Text] [Related]

  • 40. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M, Nie Z, Li Y, Gao Y, Wen X, Cao H, Zhang S.
    Front Cell Dev Biol; 2021 Dec 23; 9():699804. PubMed ID: 34869304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.